{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T07:16:17Z","timestamp":1794726977263,"version":"4.9.1"},"reference-count":179,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1378\/chest.126.3_suppl.311s","type":"journal-article","created":{"date-parts":[[2004,9,21]],"date-time":"2004-09-21T18:47:46Z","timestamp":1095792466000},"page":"311S-337S","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":629,"special_numbering":"S","title":["Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention"],"prefix":"10.1016","volume":"126","author":[{"given":"Theodore E.","family":"Warkentin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Greinacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.126.3_suppl.311S_bib1","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.311S_bib2","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/archinte.163.20.2518","article-title":"An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients","volume":"163","author":"Warkentin","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.126.3_suppl.311S_bib3","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1182\/blood-2002-05-1448","article-title":"Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia","volume":"101","author":"Hong","year":"2003","journal-title":"Blood"},{"key":"10.1378\/chest.126.3_suppl.311S_bib4","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood-2002-07-2201","article-title":"The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study","volume":"101","author":"Girolami","year":"2003","journal-title":"Blood"},{"key":"10.1378\/chest.126.3_suppl.311S_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0049-3848(03)00336-0","article-title":"Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban","volume":"110","author":"Warkentin","year":"2003","journal-title":"Thromb Res"},{"key":"10.1378\/chest.126.3_suppl.311S_bib6","series-title":"Heparin-induced thrombocytopenia","first-page":"107","article-title":"Frequency of heparin-induced thrombocytopenia","author":"Lee","year":"2004"},{"key":"10.1378\/chest.126.3_suppl.311S_bib7","series-title":"Heparin-induced thrombocytopenia","first-page":"53","article-title":"Clinical picture of heparin-induced thrombocytopenia","author":"Warkentin","year":"2004"},{"key":"10.1378\/chest.126.3_suppl.311S_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-8652(199709)56:1<12::AID-AJH3>3.0.CO;2-5","article-title":"Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution","volume":"56","author":"Nand","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib9","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(96)00258-6","article-title":"A 14-year study of heparin-induced thrombocytopenia","volume":"101","author":"Warkentin","year":"1996","journal-title":"Am J Med"},{"key":"10.1378\/chest.126.3_suppl.311S_bib10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0002-9343(99)00124-2","article-title":"Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia","volume":"106","author":"Wallis","year":"1999","journal-title":"Am J Med"},{"key":"10.1378\/chest.126.3_suppl.311S_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0037-1614206","article-title":"Heparin-induced thrombocytopenia: towards consensus","volume":"79","author":"Warkentin","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.126.3_suppl.311S_bib12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2141.2003.04334.x","article-title":"Heparin-induced thrombocytopenia: pathogenesis and management","volume":"121","author":"Warkentin","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib13","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.5858\/2002-126-1415-PCMALT","article-title":"Platelet count monitoring and laboratory testing for heparin-induced thrombocytopenia","volume":"126","author":"Warkentin","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"10.1378\/chest.126.3_suppl.311S_bib14","first-page":"A2220","article-title":"Heparininduzierte Thrombozytopenie","volume":"100","author":"Greinacher","year":"2003","journal-title":"Dtsch \u00c4rtz"},{"key":"10.1378\/chest.126.3_suppl.311S_bib15","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1365-2141.1996.d01-1481.x","article-title":"Heparin-induced skin lesions","volume":"92","author":"Warkentin","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib16","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood.V96.5.1703","article-title":"Impact of the patient population on the risk for heparin-induced thrombocytopenia","volume":"96","author":"Warkentin","year":"2000","journal-title":"Blood"},{"key":"10.1378\/chest.126.3_suppl.311S_bib17","first-page":"148","article-title":"Laboratory diagnosis of immune heparin-induced thrombocytopenia","volume":"2","author":"Warkentin","year":"2003","journal-title":"Curr Hematol Rep"},{"key":"10.1378\/chest.126.3_suppl.311S_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0038-1656329","article-title":"Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia [letter]","volume":"68","author":"Amiral","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.126.3_suppl.311S_bib19","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1182\/blood.V99.4.1230","article-title":"Defining a second epitope for heparin-induced thrombocytopenia\/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody","volume":"99","author":"Li","year":"2002","journal-title":"Blood"},{"key":"10.1378\/chest.126.3_suppl.311S_bib20","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood.V91.3.916","article-title":"Antibodies from patients with heparin-induced thrombocytopenia\/thrombosis recognize different epitopes on heparin: platelet factor 4","volume":"91","author":"Suh","year":"1998","journal-title":"Blood"},{"key":"10.1378\/chest.126.3_suppl.311S_bib21","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1046\/j.1365-2141.2000.02034.x","article-title":"Affinity purification of heparin-dependent antibodies to platelet factor 4 developed in heparin-induced thrombocytopenia: biological characteristics and effects on platelet activation","volume":"109","author":"Amiral","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib22","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1046\/j.0007-1048.2002.03363.x","article-title":"The new ID-heparin\/PF4 antibody test for rapid detection of heparin-induced antibodies in comparison with functional and antigenic assays","volume":"116","author":"Eichler","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib23","unstructured":"Council for International Organization of Medical Sciences (CIOMS). Benefit-risk balance for marketed drugs: evaluating safety signals. The report of CIOMS Working Party IV, Geneva, Switzerland, 1998"},{"key":"10.1378\/chest.126.3_suppl.311S_bib24","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM200104263441704","article-title":"Temporal aspects of heparin-induced thrombocytopenia","volume":"344","author":"Warkentin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.311S_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1378\/chest.122.1.37","article-title":"Heparin-induced thrombocytopenia: temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin","volume":"122","author":"Lubenow","year":"2002","journal-title":"Chest"},{"key":"10.1378\/chest.126.3_suppl.311S_bib26","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1055\/s-2008-1039743","article-title":"Thromboembolieprophylaxe als Ausl\u00f6ser thrombembolischer Komplikationen: Eine Untersuchung zur Inzidenz der Heparin-induzierten Thrombozytopenie (HIT) Typ II","volume":"135","author":"Ganzer","year":"1997","journal-title":"Z Orthop Ihre Grenzgeb"},{"issue":"suppl 1","key":"10.1378\/chest.126.3_suppl.311S_bib27","first-page":"A92","article-title":"Heparin-induced thrombocytopenia (HIT) in orthopedic patients- a prospective cohort trial comparing UFH and LMWH [abstract]","volume":"79","author":"Funk","year":"2000","journal-title":"Ann Hematol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0049-3848(02)00397-3","article-title":"Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies","volume":"108","author":"Ahmad","year":"2002","journal-title":"Thromb Res"},{"key":"10.1378\/chest.126.3_suppl.311S_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0003-4975(02)04349-7","article-title":"Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery","volume":"75","author":"Francis","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.126.3_suppl.311S_bib30","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1365-2141.2002.03687.x","article-title":"Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated heparin or low-molecular-weight heparin","volume":"118","author":"Lindhoff-Last","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib31","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","article-title":"Safety of low-molecular-weight heparin in pregnancy: a systematic review","volume":"81","author":"Sanson","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.126.3_suppl.311S_bib32","first-page":"1134","article-title":"Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies","volume":"108","author":"Lepercq","year":"2001","journal-title":"BJOG"},{"key":"10.1378\/chest.126.3_suppl.311S_bib33","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1471-0528.2000.tb11110.x","article-title":"Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy","volume":"107","author":"Ellison","year":"2000","journal-title":"BJOG"},{"key":"10.1378\/chest.126.3_suppl.311S_bib34","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1067\/mob.2001.114690","article-title":"Heparin-induced thrombocytopenia is rare in pregnancy","volume":"185","author":"Fausett","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib35","first-page":"74","article-title":"Fatal reactions associated with intravenous heparin","volume":"20","author":"Ansell","year":"1986","journal-title":"Drug Intell Clin Pharm"},{"key":"10.1378\/chest.126.3_suppl.311S_bib36","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0272-6386(97)90208-0","article-title":"Pseudopulmonary embolism: acute respiratory distress in the syndrome of heparin-induced thrombocytopenia","volume":"29","author":"Popov","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1378\/chest.126.3_suppl.311S_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0038-1650013","article-title":"Heparin-induced thrombocytopenia: a prospective study","volume":"43","author":"Ansell","year":"1980","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.126.3_suppl.311S_bib38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00000441-198409000-00003","article-title":"Thrombocytopenia in a prospective, randomized, double-blind trial of bovine and porcine heparin","volume":"288","author":"Green","year":"1984","journal-title":"Am J Med Sci"},{"key":"10.1378\/chest.126.3_suppl.311S_bib39","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0049-3848(84)90083-5","article-title":"Studies on the frequency of heparin-associated thrombocytopenia","volume":"33","author":"Powers","year":"1984","journal-title":"Thromb Res"},{"key":"10.1378\/chest.126.3_suppl.311S_bib40","first-page":"374","article-title":"Heparin-associated thrombocytopenia: a prospective comparison of bovine lung heparin, manufactured by new process, and porcine intestinal heparin","volume":"20","author":"Bailey","year":"1986","journal-title":"Drug Intell Clin Pharm"},{"key":"10.1378\/chest.126.3_suppl.311S_bib41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00007691-198306000-00010","article-title":"Heparin-associated thrombocytopenia: a prospective evaluation of 211 patients","volume":"5","author":"Cipolle","year":"1983","journal-title":"Ther Drug Monit"},{"key":"10.1378\/chest.126.3_suppl.311S_bib42","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.34.6.736","article-title":"Heparin-induced thrombocytopenia in patients with cerebrovascular ischemic disease","volume":"34","author":"Ramirez-Lassepas","year":"1984","journal-title":"Neurology"},{"key":"10.1378\/chest.126.3_suppl.311S_bib43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7326\/0003-4819-85-2-155","article-title":"Thrombocytopenia occurring during the administration of heparin: a prospective study in 52 patients","volume":"85","author":"Bell","year":"1976","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3_suppl.311S_bib44","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0049-3848(77)90111-6","article-title":"In vitrostudies of heparin-induced thrombocytopenia","volume":"11","author":"Alving","year":"1977","journal-title":"Thromb Res"},{"key":"10.1378\/chest.126.3_suppl.311S_bib45","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1001\/jama.1979.03290480030018","article-title":"Thrombocytopenia found uncommonly during heparin therapy","volume":"241","author":"Powers","year":"1979","journal-title":"JAMA"},{"key":"10.1378\/chest.126.3_suppl.311S_bib46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1445-5994.1980.tb03414.x","article-title":"Heparin-associated thrombocytopenia: case report and prospective study","volume":"10","author":"Gallus","year":"1980","journal-title":"Aust N Z J Med"},{"issue":"suppl","key":"10.1378\/chest.126.3_suppl.311S_bib47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0609.1980.tb02515.x","article-title":"Thrombocytes and treatment with heparin from porcine mucosa","volume":"36","author":"Holm","year":"1980","journal-title":"Scand J Haematol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00558513","article-title":"Adverse effects of three different forms of heparin therapy: thrombocytopenia, increased transaminases, and hyperkalemia","volume":"37","author":"Monreal","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib49","first-page":"1086","article-title":"Heparin-associated thrombocytopenia: low frequency in 104 patients treated with heparin of intestinal mucosal origin","volume":"120","author":"Malcolm","year":"1979","journal-title":"Can Med Assoc J"},{"key":"10.1378\/chest.126.3_suppl.311S_bib50","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1001\/archinte.1989.00390060039008","article-title":"Low incidence of thrombocytopenia with porcine mucosal heparin: a prospective multicentre study","volume":"149","author":"Rao","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.126.3_suppl.311S_bib51","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/bmj.303.6802.543","article-title":"Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin","volume":"303","author":"Leyvraz","year":"1991","journal-title":"BMJ"},{"key":"10.1378\/chest.126.3_suppl.311S_bib52","first-page":"50","article-title":"Heparin-induced thrombocytopenia","volume":"29","author":"Louridas","year":"1991","journal-title":"S Afr J Surg"},{"key":"10.1378\/chest.126.3_suppl.311S_bib53","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1046\/j.1365-2141.1998.00750.x","article-title":"High incidence of anti-heparin\/platelet factor 4 antibodies after cardiopulmonary bypass","volume":"101","author":"Trossaert","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib54","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1161\/01.CIR.99.19.2530","article-title":"Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin: clinical implications for heparin-induced thrombocytopenia","volume":"99","author":"Pouplard","year":"1999","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.311S_bib55","first-page":"16a","article-title":"Changes in the platelet count after cardiopulmonary bypass can efficiently predict the development of pathogenic heparin-dependent antibodies [abstract]","volume":"100","author":"Pouplard","year":"2002","journal-title":"Blood"},{"key":"10.1378\/chest.126.3_suppl.311S_bib56","first-page":"267","article-title":"Heparin induced thrombocytopenia: case reports and a prospective study","volume":"95","author":"Romeril","year":"1982","journal-title":"N Z Med J"},{"key":"10.1378\/chest.126.3_suppl.311S_bib57","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00007611-198202000-00018","article-title":"Effect of low-dose heparin on the platelet count","volume":"75","author":"Weitberg","year":"1982","journal-title":"South Med J"},{"key":"10.1378\/chest.126.3_suppl.311S_bib58","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/ajh.2830170404","article-title":"Heparin-induced thrombocytopenia: a prospective study","volume":"17","author":"Johnson","year":"1984","journal-title":"Am J Hematol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib59","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1592\/phco.23.6.745.32188","article-title":"Frequency of heparin-induced thrombocytopenia in critical care patients","volume":"23","author":"Verma","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1378\/chest.126.3_suppl.311S_bib60","first-page":"425","article-title":"Serologic evidence of heparin sensitization in cancer patients receiving heparin flushes of venous access devices","volume":"7","author":"Mayo","year":"1999","journal-title":"Support Care Cancer"},{"key":"10.1378\/chest.126.3_suppl.311S_bib61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2796.1999.00527.x","article-title":"Heparin-induced thrombocytopenia (HIT) due to heparin flushes: a report of three cases","volume":"246","author":"Kadidal","year":"1999","journal-title":"J Intern Med"},{"key":"10.1378\/chest.126.3_suppl.311S_bib62","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/(SICI)1096-8652(199606)52:2<90::AID-AJH4>3.0.CO;2-0","article-title":"Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin","volume":"52","author":"Amiral","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib63","series-title":"Heparin-induced thrombocytopenia","first-page":"271","article-title":"Laboratory testing for heparin-induced thrombocytopenia","author":"Warkentin","year":"2004"},{"key":"10.1378\/chest.126.3_suppl.311S_bib64","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-135-7-200110020-00009","article-title":"Delayed-onset heparin-induced thrombocytopenia and thrombosis","volume":"135","author":"Warkentin","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3_suppl.311S_bib65","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7326\/0003-4819-136-3-200202050-00009","article-title":"Delayed-onset heparin-induced thrombocytopenia","volume":"136","author":"Rice","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3_suppl.311S_bib66","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1056\/NEJM200303133481120","article-title":"Delayed-onset heparin-induced thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin [letter]","volume":"348","author":"Warkentin","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.311S_bib67","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0002-9149(99)80282-3","article-title":"Prevention of venous thrombosis after coronary artery bypass surgery (a randomized trial comparing two mechanical prophylaxis strategies)","volume":"76","author":"Goldhaber","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib68","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0022-2143(96)80009-6","article-title":"Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin: platelet factor 4 complexes","volume":"128","author":"Visentin","year":"1996","journal-title":"J Lab Clin Med"},{"key":"10.1378\/chest.126.3_suppl.311S_bib69","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.athoracsur.2003.09.034","article-title":"Heparin-induced thrombocytopenia and cardiac surgery","volume":"76","author":"Warkentin","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.126.3_suppl.311S_bib70","series-title":"Heparin-induced thrombocytopenia","first-page":"335","article-title":"Treatment of heparin-induced thrombocytopenia: an overview","author":"Greinacher","year":"2004"},{"key":"10.1378\/chest.126.3_suppl.311S_bib71","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1182\/blood.V83.6.1535.1535","article-title":"Plasma P-selectin is increased in thrombotic consumptive platelet disorders","volume":"83","author":"Chong","year":"1994","journal-title":"Blood"},{"key":"10.1378\/chest.126.3_suppl.311S_bib72","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1182\/blood.V84.11.3691.bloodjournal84113691","article-title":"Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia","volume":"84","author":"Warkentin","year":"1994","journal-title":"Blood"},{"key":"10.1378\/chest.126.3_suppl.311S_bib73","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/09537109975960","article-title":"Generation of platelet-derived microparticles and procoagulant activity by heparin-induced thrombocytopenia IgG\/serum and other IgG platelet agonists: a comparison with standard platelet agonists","volume":"10","author":"Warkentin","year":"1999","journal-title":"Platelets"},{"key":"10.1378\/chest.126.3_suppl.311S_bib74","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1046\/j.1365-2141.1996.d01-1944.x","article-title":"A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry","volume":"95","author":"Lee","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib75","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V72.3.925.bloodjournal723925","article-title":"Heparin-induced thrombocytopenia: laboratory studies","volume":"72","author":"Kelton","year":"1988","journal-title":"Blood"},{"key":"10.1378\/chest.126.3_suppl.311S_bib76","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1182\/blood.V96.1.182","article-title":"Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation","volume":"96","author":"Newman","year":"2000","journal-title":"Blood"},{"key":"10.1378\/chest.126.3_suppl.311S_bib77","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1172\/JCI116987","article-title":"Antibodies from patients with heparin-induced thrombocytopenia\/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells","volume":"93","author":"Visentin","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.126.3_suppl.311S_bib78","first-page":"247","article-title":"Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen","volume":"71","author":"Greinacher","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.126.3_suppl.311S_bib79","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1182\/blood.V97.10.3300","article-title":"Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia","volume":"97","author":"Pouplard","year":"2001","journal-title":"Blood"},{"key":"10.1378\/chest.126.3_suppl.311S_bib80","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1182\/blood.V98.4.1252","article-title":"Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8","volume":"98","author":"Arepally","year":"2001","journal-title":"Blood"},{"key":"10.1378\/chest.126.3_suppl.311S_bib81","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0887-7963(96)80001-0","article-title":"Heparin-induced thrombocytopenia: IgG-mediated platelet activation, platelet microparticle generation, and altered procoagulant\/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia","volume":"10","author":"Warkentin","year":"1996","journal-title":"Transfus Med Rev"},{"key":"10.1378\/chest.126.3_suppl.311S_bib82","doi-asserted-by":"crossref","first-page":"804","DOI":"10.7326\/0003-4819-127-9-199711010-00005","article-title":"The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia","volume":"127","author":"Warkentin","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3_suppl.311S_bib83","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1096-8652(199909)62:1<44::AID-AJH7>3.0.CO;2-F","article-title":"Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia","volume":"62","author":"Warkentin","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib84","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ajh.10181","article-title":"Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia","volume":"71","author":"Smythe","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib85","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archinte.164.1.66","article-title":"Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia","volume":"164","author":"Srinivasan","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.126.3_suppl.311S_bib86","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ajh.10440","article-title":"Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis","volume":"75","author":"Warkentin","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib87","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM199711063371901","article-title":"A comparison of recombinant hirudin with a low-molecular weight heparin to prevent thromboembolic complications after total hip replacement","volume":"337","author":"Eriksson","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.311S_bib88","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1001\/archinte.162.16.1833","article-title":"Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies","volume":"162","author":"Turpie","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.126.3_suppl.311S_bib89","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2106\/00004623-199173040-00003","article-title":"Low-molecular-weight heparinoid compared with warfarin for prophylaxis of deep-vein thrombosis in patients who are operated on for fracture of the hip: a prospective, randomized trial","volume":"73","author":"Gerhart","year":"1991","journal-title":"J Bone Joint Surg Am"},{"key":"10.1378\/chest.126.3_suppl.311S_bib90","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/bjs.1800790919","article-title":"Thromboembolic prophylaxis in total hip replacement: a comparison between the low molecular weight heparinoid Lomoparan and heparin-dihydroergotamine","volume":"79","author":"Leyvraz","year":"1992","journal-title":"Br J Surg"},{"issue":"suppl 1","key":"10.1378\/chest.126.3_suppl.311S_bib91","first-page":"535a","article-title":"Preliminary evaluation of a clinical scoring system for estimating the pretest probability of heparin-induced thrombocytopenia: the \u201c4 T's\u201d [abstract]","volume":"102","author":"Lo","year":"2003","journal-title":"Blood"},{"key":"10.1378\/chest.126.3_suppl.311S_bib92","series-title":"Heparin-induced thrombocytopenia","first-page":"397","article-title":"Lepirudin for the treatment of heparin-induced thrombocytopenia","author":"Greinacher","year":"2004"},{"key":"10.1378\/chest.126.3_suppl.311S_bib93","series-title":"Heparin-induced thrombocytopenia","first-page":"437","article-title":"Argatroban therapy in heparin-induced thrombocytopenia","author":"Lewis","year":"2004"},{"key":"10.1378\/chest.126.3_suppl.311S_bib94","series-title":"Heparin-induced thrombocytopenia","first-page":"475","article-title":"Bivalirudin for the treatment of heparin-induced thrombocytopenia","author":"Bartholomew","year":"2004"},{"key":"10.1378\/chest.126.3_suppl.311S_bib95","series-title":"Heparin-induced thrombocytopenia","first-page":"371","article-title":"Danaparoid for the treatment of heparin-induced thrombocytopenia","author":"Chong","year":"2004"},{"key":"10.1378\/chest.126.3_suppl.311S_bib96","first-page":"43","article-title":"Fondaparinux (Arixtra), a new anticoagulant","volume":"44","year":"2002","journal-title":"Med Lett Drugs Ther"},{"key":"10.1378\/chest.126.3_suppl.311S_bib97","first-page":"511","article-title":"Successful treatment of heparin-associated thrombocytopenia and thrombosis using Hirulog","volume":"11","author":"Chamberlin","year":"1995","journal-title":"Can J Cardiol"},{"issue":"suppl 1","key":"10.1378\/chest.126.3_suppl.311S_bib98","first-page":"164a","article-title":"Bivalirudin, a direct thrombin inhibitor, is a safe and effective treatment for heparin-induced thrombocytopenia [abstract]","volume":"102","author":"Francis","year":"2003","journal-title":"Blood"},{"key":"10.1378\/chest.126.3_suppl.311S_bib99","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1055\/s-0038-1649842","article-title":"Characterization of the structural requirements for a carbohydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopenia","volume":"74","author":"Greinacher","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.126.3_suppl.311S_bib100","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1055\/s-0038-1649949","article-title":"Absence ofin vitrocross-reaction of pentasaccharide with the plasma heparin-dependent factor of twenty-five patients with heparin-associated thrombocytopenia","volume":"74","author":"Elalamy","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.126.3_suppl.311S_bib101","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00001721-199703000-00005","article-title":"Absence of cross-reactivity of SR90107A\/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopenia","volume":"8","author":"Amiral","year":"1997","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"suppl 1","key":"10.1378\/chest.126.3_suppl.311S_bib102","first-page":"164a","article-title":"Comparison of heparin-induced thrombocytopenia antibody (HIT-Ab) generation andin vitrocross-reactivity after elective hip or knee replacement surgery in patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin [abstract]","volume":"102","author":"Warkentin","year":"2003","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1378\/chest.126.3_suppl.311S_bib103","first-page":"319a","article-title":"Successful treatment of heparin induced thrombocytopenia (HIT) with fondaparinux [abstract]","volume":"102","author":"Kuo","year":"2003","journal-title":"Blood"},{"key":"10.1378\/chest.126.3_suppl.311S_bib104","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1055\/s-0037-1616046","article-title":"Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopenia with thrombosis: a clinical outcome study","volume":"86","author":"Chong","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.126.3_suppl.311S_bib105","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1055\/s-0037-1615946","article-title":"A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia","volume":"85","author":"Eichler","year":"2001","journal-title":"Thromb Haemost"},{"issue":"suppl 1","key":"10.1378\/chest.126.3_suppl.311S_bib106","first-page":"626a","volume":"88","author":"Warkentin","year":"1996","journal-title":"Blood"},{"key":"10.1378\/chest.126.3_suppl.311S_bib107","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1055\/s-0038-1649626","article-title":"Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with Orgaran (Org 10172)","volume":"70","author":"Magnani","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.126.3_suppl.311S_bib108","first-page":"74","article-title":"Orgaran (danaparoid sodium) use in the syndrome of heparin-induced thrombocytopenia","volume":"8","author":"Magnani","year":"1997","journal-title":"Platelets"},{"key":"10.1378\/chest.126.3_suppl.311S_bib109","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/01.CIR.99.1.73","article-title":"Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study","volume":"99","author":"Greinacher","year":"1999","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.311S_bib110","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/01.CIR.100.6.587","article-title":"Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia","volume":"100","author":"Greinacher","year":"1999","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.311S_bib111","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1182\/blood.V96.3.846","article-title":"Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range","volume":"96","author":"Greinacher","year":"2000","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1378\/chest.126.3_suppl.311S_bib112","first-page":"704a","article-title":"Results of the third prospective study of treatment with lepirudin in patients with heparin-induced thrombocytopenia (HAT) [abstract]","volume":"100","author":"Eichler","year":"2002","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1378\/chest.126.3_suppl.311S_bib113","first-page":"502a","article-title":"Results of a large drug monitoring program confirms the safety and efficacy of Refludan (lepirudin) in patients with immune-mediated heparin-induced thrombocytopenia [abstract]","volume":"100","author":"Lubenow","year":"2002","journal-title":"Blood"},{"key":"10.1378\/chest.126.3_suppl.311S_bib114","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/01.CIR.103.14.1838","article-title":"Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia","volume":"103","author":"Lewis","year":"2001","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.311S_bib115","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archinte.163.15.1849","article-title":"Argatroban anticoagulation in patients with heparin-induced thrombocytopenia","volume":"163","author":"Lewis","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.126.3_suppl.311S_bib116","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1182\/blood.V96.7.2373","article-title":"Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance","volume":"96","author":"Eichler","year":"2000","journal-title":"Blood"},{"key":"10.1378\/chest.126.3_suppl.311S_bib117","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1182\/blood-2002-04-1055","article-title":"Antihirudin antibodies following low-dose subcutaneous treatment with desirudin for thrombosis prophylaxis after hip-replacement surgery: incidence and clinical relevance","volume":"101","author":"Greinacher","year":"2003","journal-title":"Blood"},{"key":"10.1378\/chest.126.3_suppl.311S_bib118","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1182\/blood-2003-07-2229","article-title":"Antibodies against lepirudin are polyspecific and recognize epitopes on bivalirudin","volume":"103","author":"Eichler","year":"2004","journal-title":"Blood"},{"key":"10.1378\/chest.126.3_suppl.311S_bib119","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1161\/01.CIR.0000096056.37269.14","article-title":"Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia","volume":"108","author":"Greinacher","year":"2003","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.311S_bib120","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(02)07495-0","article-title":"Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data","volume":"359","author":"Direct Thrombin Inhibitor Trialists' Collaborative Group","year":"2002","journal-title":"Lancet"},{"key":"10.1378\/chest.126.3_suppl.311S_bib121","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(02)09657-5","article-title":"Direct thrombin inhibitors in acute coronary syndromes [letter]","volume":"360","author":"Eikelboom","year":"2002","journal-title":"Lancet"},{"key":"10.1378\/chest.126.3_suppl.311S_bib122","first-page":"215","article-title":"Heparin-induced thrombocytopenia, part 2: clinical course and treatment","volume":"17","author":"Warkentin","year":"2002","journal-title":"J Crit Illn"},{"key":"10.1378\/chest.126.3_suppl.311S_bib123","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1055\/s-0037-1614355","article-title":"Lower limb veins should be systematically explored in patients with isolated heparin-induced thrombocytopenia [letter]","volume":"82","author":"Tardy","year":"1999","journal-title":"Thromb Haemost"},{"issue":"suppl 1","key":"10.1378\/chest.126.3_suppl.311S_bib124","first-page":"501a","article-title":"Meta-analysis of three prospective studies of lepirudin in the prevention of thrombosis in patients with heparin-induced thrombocytopenia [abstract]","volume":"100","author":"Lubenow","year":"2002","journal-title":"Blood"},{"key":"10.1378\/chest.126.3_suppl.311S_bib125","doi-asserted-by":"crossref","first-page":"589","DOI":"10.7326\/0003-4819-135-8_Part_1-200110160-00009","article-title":"Venous limb gangrene during warfarin treatment of cancer-associated deep venous thrombosis","volume":"135","author":"Warkentin","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3_suppl.311S_bib126","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1378\/chest.116.5.1333","article-title":"Safety of warfarin anticoagulation in patients with heparin-induced thrombocytopenia","volume":"116","author":"Wallis","year":"1999","journal-title":"Chest"},{"issue":"suppl 5","key":"10.1378\/chest.126.3_suppl.311S_bib127","first-page":"17","article-title":"Limitations of conventional treatment options for heparin-induced thrombocytopenia","volume":"35","author":"Warkentin","year":"1998","journal-title":"Semin Hematol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib128","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1378\/chest.102.5.1578-b","article-title":"Thrombocytopenia, cutaneous necrosis, and gangrene of the upper and lower extremities in a 35-year-old man","volume":"102","author":"Thomas","year":"1992","journal-title":"Chest"},{"key":"10.1378\/chest.126.3_suppl.311S_bib129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1345\/aph.16388","article-title":"Heparin-induced thrombocytopenia","volume":"32","author":"Gupta","year":"1998","journal-title":"Ann Pharmacother"},{"key":"10.1378\/chest.126.3_suppl.311S_bib130","first-page":"618","article-title":"Venous gangrene associated with heparin-induced thrombocytopenia","volume":"97","author":"Battey","year":"1985","journal-title":"Surgery"},{"key":"10.1378\/chest.126.3_suppl.311S_bib131","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1055\/s-0037-1615601","article-title":"Interpreting the international normalized ratio (INR) in individuals receiving argatroban and warfarin","volume":"85","author":"Sheth","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.126.3_suppl.311S_bib132","first-page":"91b","article-title":"Transition from argatroban to warfarin in patients with heparin-induced thrombocytopenia [abstract]","volume":"98","author":"Hiatt","year":"2001","journal-title":"Blood"},{"key":"10.1378\/chest.126.3_suppl.311S_bib133","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.beha.2004.02.002","article-title":"Bivalent direct thrombin inhibitors: hirudin and bivalirudin","volume":"17","author":"Warkentin","year":"2004","journal-title":"Baillieres Best Pract Res Clin Haematol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib134","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1055\/s-0038-1648491","article-title":"Heparin-associated thrombocytopenia: antibody is not heparin-specific","volume":"67","author":"Greinacher","year":"1992","journal-title":"Thromb Haemost"},{"issue":"suppl 1","key":"10.1378\/chest.126.3_suppl.311S_bib135","first-page":"P198","article-title":"The use of low-molecular-weight heparins in heparin-induced thrombocytopenia (HIT): a cohort study [abstract]","volume":"79","author":"Ranze","year":"2000","journal-title":"Ann Hematol"},{"issue":"suppl 1","key":"10.1378\/chest.126.3_suppl.311S_bib136","first-page":"10","article-title":"The appropriate use of platelets: an update from the Edinburgh Consensus Conference","volume":"101","author":"Contreras","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib137","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1365-2141.2003.04468.x","article-title":"Guidelines for the use of platelet transfusions","volume":"122","author":"British Committee for Standards in Haematology, Blood Transfusion Task Force","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib138","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1056\/NEJM197607292950501","article-title":"Heparin-induced thrombocytopenia","volume":"295","author":"Babcock","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.311S_bib139","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ajh.2830060204","article-title":"Heparin-induced thrombocytopenia: association with a platelet aggregating factor and arterial thromboses","volume":"6","author":"Cimo","year":"1979","journal-title":"Am J Hematol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1056\/NEJM200008173430718","article-title":"Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia [letter]","volume":"343","author":"P\u00f6tzsch","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.311S_bib141","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1213\/00000539-200302000-00009","article-title":"Patients with a history of type II heparin-induced thrombocytopenia with thrombosis requiring cardiac surgery with cardiopulmonary bypass: a prospective observational case series","volume":"96","author":"Nuttall","year":"2003","journal-title":"Anesth Analg"},{"key":"10.1378\/chest.126.3_suppl.311S_bib142","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0022-5223(19)38447-8","article-title":"Cardiopulmonary bypass for patients with previously documented heparin-indued platelet aggregation","volume":"87","author":"Olinger","year":"1984","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1378\/chest.126.3_suppl.311S_bib143","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0003-4975(00)02430-9","article-title":"Emergency cardiopulmonary bypass in a bilaterally nephrectomized patient with a history of heparin-induced thrombocytopenia: successful reexposure to heparin","volume":"71","author":"Selleng","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.126.3_suppl.311S_bib144","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0003-4975(02)04309-6","article-title":"Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use","volume":"75","author":"Lubenow","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.126.3_suppl.311S_bib145","series-title":"Heparin-induced thrombocytopenia","first-page":"531","article-title":"Management of cardiopulmonary bypass anticoagulation in patients with heparin-induced thrombocytopenia","author":"Poetzsch","year":"2004"},{"key":"10.1378\/chest.126.3_suppl.311S_bib146","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.athoracsur.2003.09.061","article-title":"Bivalirudin versus heparin and protamine in off pump coronary artery bypass surgery","volume":"77","author":"Merry","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.126.3_suppl.311S_bib147","first-page":"SCA1","article-title":"Off pump CABG in a patient with HITT anticoagulated with bivalirudin: a case report [abstract]","volume":"93","author":"Spiess","year":"2002","journal-title":"Anesth Analg"},{"key":"10.1378\/chest.126.3_suppl.311S_bib148","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0003-4975(03)00144-9","article-title":"Bivalirudin in off-pump myocardial revascularization in patients with heparin-induced thrombocytopenia","volume":"76","author":"Bott","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.126.3_suppl.311S_bib149","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/S0003-4975(02)04125-5","article-title":"Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery","volume":"74","author":"Vasquez","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.126.3_suppl.311S_bib150","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0003-4975(02)04299-6","article-title":"Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass","volume":"75","author":"Davis","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.126.3_suppl.311S_bib151","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF03042629","article-title":"Rekombinantes Hirudin als Antikoagulans f\u00fcr den kardiopulmonalen Bypass in der Herzchirurgie: Klinische Erfahrungen","volume":"11","author":"Riess","year":"1997","journal-title":"Z Herz Thorax Gef\u00c4\u03b2chir"},{"key":"10.1378\/chest.126.3_suppl.311S_bib152","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00000542-199809000-00029","article-title":"Emergent cardiopulmonary bypass in five patients with heparin-induced thrombocytopenia type II employing recombinant hirudin","volume":"89","author":"Koster","year":"1998","journal-title":"Anesthesiology"},{"key":"10.1378\/chest.126.3_suppl.311S_bib153","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/cr.2000.5861","article-title":"Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: a 1-year experience in 57 patients","volume":"14","author":"Koster","year":"2000","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1378\/chest.126.3_suppl.311S_bib154","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00000539-200107000-00007","article-title":"The relationship between hirudin and activated clotting time: implications for patients with heparin-induced thrombocytopenia undergoing cardiac surgery","volume":"93","author":"Despotis","year":"2001","journal-title":"Anesth Analg"},{"key":"10.1378\/chest.126.3_suppl.311S_bib155","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/cr.2000.5846","article-title":"Management of urgent high-risk cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and coexisting disorders of renal function: use of heparin and epoprostenol combined with on-line monitoring of platelet function","volume":"14","author":"Mertzlufft","year":"2000","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1378\/chest.126.3_suppl.311S_bib156","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0003-4975(00)02022-1","article-title":"Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia","volume":"71","author":"Aouifi","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.126.3_suppl.311S_bib157","first-page":"354","article-title":"Cardiac surgery in patients with heparin-induced thrombocytopenia using preoperatively determined dosages of iloprost","volume":"5","author":"Antoniou","year":"2002","journal-title":"Heart Surg Forum"},{"key":"10.1378\/chest.126.3_suppl.311S_bib158","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/S0003-4975(00)01888-9","article-title":"Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb\/IIIa inhibitor tirofiban as anticoagulant","volume":"70","author":"Koster","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.126.3_suppl.311S_bib159","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00000542-200102000-00013","article-title":"Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb\u2013IIIa antagonist tirofiban","volume":"94","author":"Koster","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1378\/chest.126.3_suppl.311S_bib160","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1067\/mtc.2001.118271","article-title":"One-year experience with the platelet glycoprotein IIb\/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II","volume":"122","author":"Koster","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1378\/chest.126.3_suppl.311S_bib161","series-title":"New anticoagulants for the cardiovascular patient","first-page":"487","article-title":"Orgaran anticoagulation for cardiopulmonary bypass in patients with heparin-induced thrombocytopenia","author":"Magnani","year":"1997"},{"key":"10.1378\/chest.126.3_suppl.311S_bib162","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/S0003-4975(01)02583-8","article-title":"Off-pump coronary artery bypass grafting for acute heparin-induced thrombocytopenia","volume":"72","author":"Warkentin","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.126.3_suppl.311S_bib163","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1067\/mtc.2003.103","article-title":"Heparin vs danaparoid in off-pump coronary bypass grafting: results of a prospective randomized clinical trial","volume":"125","author":"Carrier","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1378\/chest.126.3_suppl.311S_bib164","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1213\/01.ANE.0000052381.47101.A2","article-title":"Hemostatic analysis of a patient undergoing off-pump coronary artery bypass surgery with argatroban anticoagulation","volume":"96","author":"Kieta","year":"2003","journal-title":"Anesth Analg"},{"key":"10.1378\/chest.126.3_suppl.311S_bib165","first-page":"177","article-title":"Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia","volume":"57","author":"Lewis","year":"2002","journal-title":"Cathet Cardiovasc Interv"},{"key":"10.1378\/chest.126.3_suppl.311S_bib166","first-page":"37","article-title":"Bivalirudin (Angiomax) for angioplasty","volume":"43","year":"2001","journal-title":"Med Lett Drugs Ther"},{"key":"10.1378\/chest.126.3_suppl.311S_bib167","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/jama.289.7.853","article-title":"Bivalirudin and provisional glycoprotein IIb\/IIIa blockade compared with heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial","volume":"289","author":"Lincoff","year":"2003","journal-title":"JAMA"},{"key":"10.1378\/chest.126.3_suppl.311S_bib168","first-page":"468","article-title":"Lepirudin as a safe alternative for effective anticoagulation in patients with known heparin-induced thrombocytopenia undergoing percutaneous coronary intervention: case reports","volume":"52","author":"Manfredi","year":"2001","journal-title":"Cathet Cardiovasc Interv"},{"key":"10.1378\/chest.126.3_suppl.311S_bib169","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/0735-1097(95)00371-1","article-title":"Recombinant hirudin (HBW 023) prevents troponin T release after coronary angioplasty in patients with unstable angina","volume":"26","author":"Rupprecht","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib170","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJM199509213331203","article-title":"A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators","volume":"333","author":"Serruys","year":"1995","journal-title":"N Engl J Med"},{"issue":"suppl F","key":"10.1378\/chest.126.3_suppl.311S_bib171","first-page":"14F","article-title":"Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention","volume":"12","author":"Campbell","year":"2000","journal-title":"J Invasive Cardiol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib172","first-page":"611","article-title":"The Anticoagulant Therapy with Bivalirudin to Assist in the Performance of Percutaneous Coronary Intervention in Patients with Heparin-Induced Thrombocytopenia (ATBAT) Study: main results","volume":"15","author":"Mahaffey","year":"2003","journal-title":"J Invasive Cardiol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib173","first-page":"318","article-title":"Orgaran during rotational atherectomy in the setting of heparin-induced thrombocytopenia","volume":"45","author":"Hale","year":"1998","journal-title":"Cathet Cardiovasc Diagn"},{"key":"10.1378\/chest.126.3_suppl.311S_bib174","first-page":"352","article-title":"Combined use of Orgaran and Reopro during coronary angioplasty in patients unable to receive heparin","volume":"46","author":"Cantor","year":"1999","journal-title":"Cathet Cardiovasc Interv"},{"key":"10.1378\/chest.126.3_suppl.311S_bib175","series-title":"Heparin-induced thrombocytopenia.","first-page":"509","article-title":"Hemodialysis in heparin-induced thrombocytopenia","author":"Fischer","year":"2004"},{"key":"10.1378\/chest.126.3_suppl.311S_bib176","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1525-139X.2003.03014.x","article-title":"Alternative methods of anticoagulation for dialysis-dependent patients with heparin-induced thrombocytopenia","volume":"16","author":"O'Shea","year":"2003","journal-title":"Semin Dial"},{"key":"10.1378\/chest.126.3_suppl.311S_bib177","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000046252","article-title":"A case review: anticoagulation in hemodialysis patients with heparin-induced thrombocytopenia","volume":"21","author":"Chuang","year":"2001","journal-title":"Am J Nephrol"},{"key":"10.1378\/chest.126.3_suppl.311S_bib178","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1563-2571.2002.02019.x","article-title":"Long-term citrate anticoagulation for high-flux haemodialysis in a patient with heparin-induced thrombocytopenia type II","volume":"29","author":"Unver","year":"2002","journal-title":"Acta Med Austriaca"},{"key":"10.1378\/chest.126.3_suppl.311S_bib179","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/S0003-4975(01)02534-6","article-title":"Heparin-induced thrombocytopenia: bovine versus porcine heparin in cardiopulmonary bypass surgery","volume":"71","author":"Konkle","year":"2001","journal-title":"Ann Thorac Surg"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215314963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215314963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:43:13Z","timestamp":1757918593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215314963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":179,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0012369215314963"],"URL":"https:\/\/doi.org\/10.1378\/chest.126.3_suppl.311s","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.126.3_suppl.311S","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}